TY - JOUR
T1 - 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands
AU - Kim, Changhoon
AU - Ann, Jihyae
AU - Lee, Sunho
AU - Kim, Eunhye
AU - Choi, Sun
AU - Blumberg, Peter M.
AU - Frank-Foltyn, Robert
AU - Bahrenberg, Gregor
AU - Stockhausen, Hannelore
AU - Christoph, Thomas
AU - Lee, Jeewoo
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/8/15
Y1 - 2018/8/15
N2 - A series of 2-(3,5-substituted 4-aminophenyl)acetamide and propanamide derivatives were investigated as human TRPV1 antagonists. The analysis of the structure-activity relationship indicated that 2-(3,5-dihalo 4-aminophenyl)acetamide analogues displayed excellent antagonism of hTRPV1 activation by capsaicin and showed improved potency compared to the corresponding propanamides. The most potent antagonist (36) exhibited potent and selective antagonism for hTRPV1 not only to capsaicin but also to NADA and elevated temperature; however, it only displayed weak antagonism to low pH. Further studies indicated that oral administration of antagonist 36 blocked the hypothermic effect of capsaicin in vivo but demonstrated hyperthermia at that dose. A docking study of 36 was performed in our established hTRPV1 homology model to understand its binding interactions with the receptor and to compare with that of previous antagonist 1.
AB - A series of 2-(3,5-substituted 4-aminophenyl)acetamide and propanamide derivatives were investigated as human TRPV1 antagonists. The analysis of the structure-activity relationship indicated that 2-(3,5-dihalo 4-aminophenyl)acetamide analogues displayed excellent antagonism of hTRPV1 activation by capsaicin and showed improved potency compared to the corresponding propanamides. The most potent antagonist (36) exhibited potent and selective antagonism for hTRPV1 not only to capsaicin but also to NADA and elevated temperature; however, it only displayed weak antagonism to low pH. Further studies indicated that oral administration of antagonist 36 blocked the hypothermic effect of capsaicin in vivo but demonstrated hyperthermia at that dose. A docking study of 36 was performed in our established hTRPV1 homology model to understand its binding interactions with the receptor and to compare with that of previous antagonist 1.
KW - Analgesic
KW - TRPV1 antagonists
KW - Vanilloid receptor 1
UR - http://www.scopus.com/inward/record.url?scp=85050882647&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2018.07.040
DO - 10.1016/j.bmc.2018.07.040
M3 - Article
C2 - 30078610
AN - SCOPUS:85050882647
SN - 0968-0896
VL - 26
SP - 4509
EP - 4517
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
IS - 15
ER -